Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Op-Eds
Why Stop with Non-Judges?
Senate Democrats have urged President Bush to appoint to the Supreme Court candidates from outside the judiciary. Their idea is to add diversity of…
Op-Eds
No Fizz in Soda Scare
The food police filed a petition this week with the federal government to require that regular (non-diet) soft drinks carry health warning labels. But…
Op-Eds
Short-Term Memory
An unwitting yet hideous example of the politically correct, “can't-we-move-on” short memories of the elites exposed in Tony Blankley's spot-on analysis “Short memories,…
Op-Eds
‘Big Lie’ Enough to Make Drug Industry Ill
Activism can be a good thing. We all benefit from getting to shop in the marketplace of ideas. However, all is not good-faith activism. Take,…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CIVIL LIBERTIES Members of Congress move to restrict some of the most controversial elements…
Newsletter
The Competitive Enterprise Institute Daily Update
1. REGULATION Washington Post columnist Cindy Skrzycki cites CEI’s most recent regulatory study, Ten Thousand Commandments. CEI Expert Available to Comment:…